Gossamer Bio, Inc. ( GOSS) - Stock Earnings
GOSS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
GOSS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -47.2 million USD | 13.8 million USD |
| 2026Q1 | -46.7 million USD | 17.0 million USD |
| 2026Q2 | 16.9 million USD | 9.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
GOSS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -179.8 million USD | — USD |
| 2024 | -56.5 million USD | 114.7 million USD |
| 2025 | -170.4 million USD | 48.5 million USD |
| 2026 Est. | — | — |
GOSS
Price: $8.77
52 week price:
Earnings Per Share: -0.60 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 916653
Market Capitalization: 65.4 million